A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia
Hyperuricemia is an independent risk factor in chronic kidney disease (CKD). Allopurinol and febuxostat are prescription medicines used to treat hyperuricemia but suffer side-effects. Earlier clinical study ha...
Source: BMC Complementary and Alternative Medicine - Category: Complementary Medicine Authors: Usharani Pingali, Chandrasekhar Nutalapati, Niranjan Koilagundla and Gangadhar Taduri Tags: Research article Source Type: research